Oral liquid for treating chronic atrophic gastritis

Abstract

The invention belongs to the technical field of traditional Chinese medicines and relates to oral liquid for treating chronic atrophic gastritis. The oral liquid is prepared by the following components in parts by weight: 10 parts of Zhejiang white atractylodes rhizome, 15 parts of poria cocos, 10 parts of orange peel, 10 parts of pinellia tenata breit, 10 parts of vinegar rhizoma cyperi, 10 parts of fructus amomi, 10 parts of mangnolia officinalis, 10 parts of vinegar curcuma aromatic, 15 parts of artemisia anomala, 6 parts of cassia twig, 10 parts of rhizoma corydalis, 10 parts of hawthorn, 10 parts of roasted malt, 10 parts of roasted medicated leaven, 10 parts of lindera aggregate, 15 parts of radix paeoniae alba, 12 parts of radix pseudostellariae and 3 parts of liquorice. The oral liquid provided by the invention has the effects of relieving inflammatory cell infiltration, regulating cellular immunity and humoral immunity function, restraining the activity of pepsinogen to promote proliferation and recovery thereof, strengthening barrier protection function of the mucosa, regulating gastrointestinal motility, increasing permeability of gastric mucosa, improving blood circulation of the mucosa, promoting atrophic glands to recover, and delaying or reversing progression of diseases.

Description

technical field [0001] The invention relates to a traditional Chinese medicine oral liquid, in particular to an oral liquid for treating chronic atrophic gastritis. Background technique [0002] Chronic atrophic gastritis (CAG) is a common clinical disease and frequently-occurring disease, which belongs to the category of "fullness" in traditional Chinese medicine. Difficulty in digestion, belching, acid reflux, fatigue, or sallow complexion, loose stools and other symptoms, and malnutrition and anemia can be seen in the later stage. Due to the long course of the disease, patients with moderate or above dysplasia may evolve along the pattern of chronic gastritis → gastric mucosal atrophy → intestinal metaplasia → dysplasia → gastric cancer. The incidence rate has great clinical significance. So far, Western medicine has no good treatment for this disease. Although Chinese medicine has shown obvious advantages in treatment, most of them are treated with decoction and synd...

AI Technical Summary

Problems solved by technology

So far, western medicine has no good treatment for this disease. Although traditional Chinese medicine has shown obvious advantages in treatment, most of them are treated with decoction and syndrome differentiation.

There are very few Chinese patent medicines that have been developed and marketed, and the curative effect is not satisfactory. Therefore, it is an urgent task to strengthen the research on the prescriptions and medicines for the treatment of chronic atrophic gastritis, and to seek ideal treatment methods and Chinese patent medicines.

Images